Drug interactions
Octreotide + Umeclidinium-vilanterol
Severity: Minor
Octreotide and Umeclidinium-vilanterol: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Octreotide can cause bradycardia and conduction abnormalities, including QT prolongation in some patients. Vilanterol may add to arrhythmic risk, though the clinical effect is generally small.
What this interaction means in plain words
Octreotide and Umeclidinium-vilanterol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Octreotide belongs to Endocrine; Umeclidinium-vilanterol belongs to Respiratory.
Why it happens
Possible additive QT effects; octreotide's effect on QT is modest.
What to do
No routine change is required. Consider an ECG in patients with other QT risk factors or established cardiac disease.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Octreotide and Umeclidinium-vilanterol, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Umeclidinium-vilanterol
Other interactions of Octreotide
Frequently asked questions
Can I take Octreotide with Umeclidinium-vilanterol?
MediHelp rates the interaction as minor. Octreotide and Umeclidinium-vilanterol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Octreotide can cause bradycardia and conduction abnormalities, including QT prolongation in some patients. Vilanterol may add to arrhythmic risk, though the clinical effect is generally small.
How serious is the interaction between Octreotide and Umeclidinium-vilanterol?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is required. Consider an ECG in patients with other QT risk factors or established cardiac disease.
What other medicines interact with Umeclidinium-vilanterol?
MediHelp also lists interactions of Umeclidinium-vilanterol with, for example, Aclidinium, Amiodarone, Amitriptyline. The full list is on the Umeclidinium-vilanterol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
